Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Poseida Therapeutics, Inc.
| Metric | Poseida Therapeutics, Inc. PSTXHealthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $65M |
| Net income (latest) | −$123M |
| Operating margin | −200.2% |
| Net margin | −190.8% |
| Return on equity | −119.0% |
| Return on assets | −45.1% |
| Return on capital (ROCE) | −63.9% |
| Debt / equity | 1.64× |
| Revenue growth (YoY) | −50.4% |
| Altman Z″ (distress) | -5.90 |
| Accruals / assets | −11.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.